UK markets open in 6 hours 40 minutes

United Therapeutics Corp (UTH.DU)

Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
240.90-1.20 (-0.50%)
At close: 07:30PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,498,300
2,327,500
1,936,300
1,685,500
1,483,300
Cost of revenue
278,100
257,500
151,600
122,500
108,100
Gross profit
2,220,200
2,070,000
1,784,700
1,563,000
1,375,200
Operating expenses
Research development
429,200
408,000
322,900
540,100
357,700
Selling general and administrative
534,200
477,100
482,100
467,000
423,900
Total operating expenses
963,400
885,100
805,000
1,007,100
781,600
Operating income or loss
1,256,800
1,184,900
979,700
555,900
593,600
Interest expense
58,800
59,300
32,400
18,600
23,500
Total other income/expenses net
-4,300
-14,000
-41,900
39,900
40,200
Income before tax
1,381,000
1,274,300
950,600
593,900
638,900
Income tax expense
330,500
289,500
223,300
118,100
124,100
Income from continuing operations
1,050,500
984,800
727,300
475,800
514,800
Net income
1,050,500
984,800
727,300
475,800
514,800
Net income available to common shareholders
1,050,500
984,800
727,300
475,800
514,800
Basic EPS
19.28
21.04
15.98
10.60
11.65
Diluted EPS
18.13
19.81
15.00
10.06
11.54
Basic average shares
46,550
46,800
45,500
44,900
44,200
Diluted average shares
49,550
49,700
48,500
47,300
44,600